RAPT Therapeutics, Inc. (RAPT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.46M | -11.27M | -52.41M | -10.44M | -17.62M | -28.15M | -27.08M | -27.75M | -21.88M | -28.81M | -18.6M | -22.85M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 29.3% | 59.97% | -93.52% | 62.39% | 19.48% | 2.27% | -45.6% | -21.47% | -27.61% | -89.59% | -19.41% | -10.48% |
| Net Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M |
| Depreciation & Amortization | 205K | 228K | 252K | 287K | 297K | 305K | 314K | 323K | 908K | 269K | 883K | 252K |
| Stock-Based Compensation | 5.03M | 4.54M | 4.65M | 4.59M | 4.56M | 5.38M | 5.4M | 4.43M | 0 | 4.24M | 0 | 3.02M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -257K | -256K | -109K | 54K | 32K | -164K | -399K | -640K | 2.77M | -1.58M | 2.65M | -265K |
| Working Capital Changes | 145K | 1.86M | -40.04M | 37.88M | -4.08M | -6.02M | -1.88M | -990K | 5.81M | -6.46M | 7.13M | -2.91M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 328K | 4.47M | -4.57M | 3.09M | -4.39M | -6.43M | -728K | -71K | 6.38M | -6.25M | 7.28M | -263K |
| Cash from Investing | 8.47M | -7.26M | -57.06M | -843K | 18.45M | 19.21M | 15.89M | 20.64M | 25.75M | 32.44M | 25.31M | -41.27M |
| Capital Expenditures | 0 | -40K | -43K | -1K | -17K | 1K | -105K | -67K | -66K | -233K | -759K | -49K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.22M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41.22M |
| Cash from Financing | 36K | 161K | 0 | 143.12M | 0 | 701K | 9.04M | 458K | 106K | 767K | 116K | 75.36M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 36K | 161K | 0 | 1000K | 0 | 701K | 1000K | 458K | 106K | 0 | 116K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 77K | 0 | 0 | 67K | 0 | 0 | 767K | 0 | 334K |
| Net Change in Cash | -3.96M | -18.37M | -109.48M | 131.84M | 823K | -8.24M | -2.16M | -6.66M | 3.97M | 4.4M | 6.82M | 11.24M |
| Free Cash Flow | -12.46M | -11.31M | -52.46M | -10.44M | -17.64M | -28.15M | -27.19M | -27.82M | -21.95M | -29.04M | -19.36M | -22.9M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 29.37% | 59.82% | -92.93% | 62.48% | 19.64% | 3.06% | -40.43% | -21.5% | -27.39% | -84.26% | -23.11% | -8.65% |
| FCF per Share | -0.46 | -0.42 | -1.95 | -1.79 | -3.63 | -5.79 | -5.63 | -5.80 | -4.58 | -6.06 | -4.05 | -5.13 |
| FCF Conversion (FCF/Net Income) | 0.71x | 0.64x | 3.05x | 0.20x | 0.96x | 1.02x | 0.89x | 0.90x | 0.70x | 1.14x | 0.64x | 1.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |